 Parkinson Disease
"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Descriptor ID |
D010300
|
| MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
| Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 5 | 1 | 6 | | 2001 | 4 | 1 | 5 | | 2002 | 4 | 2 | 6 | | 2003 | 6 | 0 | 6 | | 2004 | 3 | 1 | 4 | | 2005 | 3 | 2 | 5 | | 2006 | 0 | 1 | 1 | | 2007 | 9 | 1 | 10 | | 2008 | 8 | 1 | 9 | | 2009 | 6 | 2 | 8 | | 2010 | 2 | 1 | 3 | | 2011 | 13 | 2 | 15 | | 2012 | 10 | 1 | 11 | | 2013 | 10 | 1 | 11 | | 2014 | 14 | 2 | 16 | | 2015 | 13 | 1 | 14 | | 2016 | 17 | 1 | 18 | | 2017 | 35 | 0 | 35 | | 2018 | 21 | 2 | 23 | | 2019 | 21 | 3 | 24 | | 2020 | 26 | 4 | 30 | | 2021 | 19 | 1 | 20 | | 2022 | 23 | 1 | 24 | | 2023 | 34 | 0 | 34 | | 2024 | 24 | 1 | 25 | | 2025 | 19 | 1 | 20 | | 2026 | 6 | 3 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Iveson MH, Mukherjee M, Davidson EM, Zhang H, Sherlock L, Ball EL, Mair G, Hosking A, Whalley H, Poon MTC, Wardlaw JM, Kent DM, Tobin R, Grover C, Alex B, Whiteley W. Clinically reported covert cerebrovascular disease and risk of neurological disease: a whole-population cohort of 367 988 people using natural language processing. J Neurol Neurosurg Psychiatry. 2026 Jun 12; 97(7):630-638.
-
Seshadri S, Akbar U, Auinger P, Lessard NA, Dini M, Norton SA, Lum HD, Holtrop JS, Miyasaki JM, Vaughan CL, Kluger BM. Reach of Palliative Care in Parkinson Disease: Progress and Gaps After a National Team-Based Implementation Project. Neurol Clin Pract. 2026 Aug; 16(4):e200628.
-
Carlisle TC, Gunn-Sandell LB, Lippitt WL, Zhu S, Medina LD, Holden SK, Amara AW, Bettcher BM, Carlson NE. Refining the Parkinson's Disease Risk Estimator for Decline In Cognition Tool (PREDICT). Cogn Behav Neurol. 2026 06 01; 39(2):64-73.
-
Yariz K, Akbostanci MC, Sayar Akaslan D, Ayidaga T, Bayram E, Yilmaz R. Suicidality in Parkinson's disease: a controlled study and review of literature. Neurol Sci. 2026 Mar 17; 47(4).
-
Yilmaz S, Aslam S, Sillau S, Katz M, Kluger B. Bridging the gap: Evaluating a community-based palliative care intervention for underserved patients with Parkinson's disease. Parkinsonism Relat Disord. 2026 May; 146:108262.
-
Fullard ME, Shelton E, Dafoe A, Kern DS, Morris MA, Matlock DD. Development and acceptability of a deep brain stimulation surgery decision aid for Parkinson's disease. J Parkinsons Dis. 2026 May; 16(3):589-598.
-
Nelson CA, Obray JD, Roll CR, Williams PE, Smith KJ, Harris WT, Hafen CW, Burris MD, Manwaring KH, Adams DN, Weber KS, Hope S, Mitchell UH, Yorgason JT, Steffensen SC. Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease. Am J Pathol. 2026 May; 196(5):1188-1204.
-
Coughlin DG, Adler CH, Barbosa W, Feuerstein J, Galasko D, Gunzler SA, Jimenez-Shahed J, Kannarkat GT, Lang AE, Martinez-Lemus JD, LeWitt PA, Pantelyat A, Schiess MC, Schwarzschild M, Siderowf AD, Simuni T, Tropea TF, Thordarson D, Vila C, Adams JL, Rosenthal L. CSF a-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps. Neurology. 2026 Feb 10; 106(3):e214648.
-
Dang NH, Kern DS, Honce JM, Ojemann SG, Tanabe JL. Skull Lesions after MR-Guided High-Intensity Focused Ultrasound: A Case Series. AJNR Am J Neuroradiol. 2026 Jan 05; 47(1):126-130.
-
Rodrigues FR, Bolner G, Ribeiro GBES, Koppanatham A, da Silva RV, Fearon C, Schumacher Schuh AF, Bayram E, Couto JBM, Ushe M, Di Luca DG. Racial and Ethnic Diversity in Clinical Trials for Disease Modifying Drugs in Parkinson Disease: A Systematic Review & Meta-Analysis. Mov Disord Clin Pract. 2026 May; 13(5):1295-1300.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|